These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 22794786)

  • 1. Gene therapy approaches for lysosomal storage disease: next-generation treatment.
    Byrne BJ; Falk DJ; Clément N; Mah CS
    Hum Gene Ther; 2012 Aug; 23(8):808-15. PubMed ID: 22794786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lysosomal storage diseases: recent patents and future strategies.
    Ortolano S; Viéitez I; Navarro C; Spuch C
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):9-25. PubMed ID: 24433521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal storage diseases: from pathophysiology to therapy.
    Parenti G; Andria G; Ballabio A
    Annu Rev Med; 2015; 66():471-86. PubMed ID: 25587658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in therapies for neurological lysosomal storage disorders.
    Ellison S; Parker H; Bigger B
    J Inherit Metab Dis; 2023 Sep; 46(5):874-905. PubMed ID: 37078180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for lysosomal storage disorders.
    Barranger JM; Novelli EA
    Expert Opin Biol Ther; 2001 Sep; 1(5):857-67. PubMed ID: 11728220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for the treatment of lysosomal storage diseases (review).
    Parenti G; Pignata C; Vajro P; Salerno M
    Int J Mol Med; 2013 Jan; 31(1):11-20. PubMed ID: 23165354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in therapeutic approaches for lysosomal storage diseases.
    Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for lysosomal storage diseases (LSDs) in large animal models.
    Haskins M
    ILAR J; 2009; 50(2):112-21. PubMed ID: 19293456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.
    Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P
    Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.
    Biffi A
    Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
    Thomas R; Kermode AR
    Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving therapies in neuronopathic LSDs: opportunities and challenges.
    Rajan DS; Escolar ML
    Metab Brain Dis; 2022 Oct; 37(7):2245-2256. PubMed ID: 35442005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for gene therapy clinical trials of lysosomal storage disorders.
    Rossi A; Malvagia S; la Marca G; Parenti G; Brunetti-Pierri N
    Mol Ther; 2024 Sep; 32(9):2930-2938. PubMed ID: 38850023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNS-directed gene therapy for lysosomal storage diseases.
    Sands MS; Haskins ME
    Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Approaches in Lysosomal Storage Diseases.
    Fernández-Pereira C; San Millán-Tejado B; Gallardo-Gómez M; Pérez-Márquez T; Alves-Villar M; Melcón-Crespo C; Fernández-Martín J; Ortolano S
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for lysosomal storage diseases: progress, challenges and future prospects.
    Seregin SS; Amalfitano A
    Curr Pharm Des; 2011; 17(24):2558-74. PubMed ID: 21774776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary redesign of the lysosomal enzyme arylsulfatase A increases efficacy of enzyme replacement therapy for metachromatic leukodystrophy.
    Simonis H; Yaghootfam C; Sylvester M; Gieselmann V; Matzner U
    Hum Mol Genet; 2019 Jun; 28(11):1810-1821. PubMed ID: 30657900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.
    Macauley SL
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1(Suppl 1):639-48. PubMed ID: 27491211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.